scholarly journals THE MORPHOLOGICAL FEATURES OF VARIANTS OF GIANT CELL TUMOR STRUCTURE

2010 ◽  
Vol 16 (1) ◽  
pp. 139-145
Author(s):  
M. Yu. Zaytseva ◽  
Ph. Yu. Zasulsky
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Treatment Approach ◽  
Cell Tumor ◽  
Long Term Results ◽  
Results Of Treatment ◽  
Morphological Criteria ◽  
Histopathologic Feature

The morphological criteria of giant cell tumor and the different ways of the run of the disease were designated as the result of collation between the histopathologic feature with the clinicoradiographic dates and the long-term results of treatment of 101 of patients. These findings promote a better collaboration of pathologist and surgeons. In future these results could be used for creating an algorithm of determination of the surgery extent and treatment approach.

scholarly journals Giant Cell Tumor of Bone: Oncological and Functional Results of Long-term Follow-up

1998 ◽  
Vol 28 (5) ◽  
pp. 323-328 ◽  
Author(s):  
Y. Oda ◽  
H. Miura ◽  
M. Tsuneyoshi ◽  
Y. Iwamoto
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Functional Results ◽  
Cell Tumor ◽  
Long Term Follow Up

Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab

2014 ◽  
Vol 14 (7) ◽  
pp. e15-e21 ◽  
Author(s):  
Tobias A. Mattei ◽  
Edwin Ramos ◽  
Azeem A. Rehman ◽  
Andrew Shaw ◽  
Shreyasumar R. Patel ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Cell Tumor ◽  
Complete Regression

scholarly journals Long-term efficacy of denosumab in giant cell tumor of bone: Results of an open-label phase 2 study

2017 ◽  
Vol 28 ◽  
pp. v645-v646 ◽  
Author(s):  
E. Palmerini ◽  
J-Y. Blay ◽  
A. Le Cesne ◽  
P. Reichardt ◽  
P. Rutkowski ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Cell Tumor ◽  
Phase 2 ◽  
Open Label ◽  
Term Efficacy ◽  
Phase 2 Study ◽  
Open Label Phase

A case of secondary malignant giant-cell tumor of bone with p53 mutation after long-term follow-up

2011 ◽  
Vol 42 (5) ◽  
pp. 727-733 ◽  
Author(s):  
Tsuyoshi Saito ◽  
Hiroyuki Mitomi ◽  
Hiroshi Izumi ◽  
Yoshiyuki Suehara ◽  
Taketo Okubo ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
P53 Mutation ◽  
Cell Tumor ◽  
Long Term Follow Up ◽  
Malignant Giant Cell Tumor

scholarly journals Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor

2015 ◽  
Vol 21 (2) ◽  
pp. 143 ◽  
Author(s):  
GurinderSingh Gosal ◽  
Avneet Boparai ◽  
GurpreetSingh Makkar
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Proximal Femur ◽  
Cell Tumor ◽  
Endoprosthetic Replacement ◽  
Term Outcome ◽  
Long Term Outcome

Tricortical Bone Grafting with Limited Midcarpal and Carpometacarpal Fusion for the Treatment of Giant Cell Tumor of the Capitate

2020 ◽  
Author(s):  
Byron E. Chalidis ◽  
Christos G. Dimitriou ◽  
Panagiotis K. Givissis
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Bone Grafting ◽  
Functional Result ◽  
Cell Tumor ◽  
Satisfactory Outcome ◽  
Long Term Follow Up ◽  
Rare Lesion

Abstract Background Giant cell tumor (GCT) of capitate is a rare lesion that is challenging to treat. Case Description We present a case of a 12-year-old girl suffering from a GCT of the capitate. Wide excision combined with adjuvant treatment including hydrogen peroxide, alcohol, tricortical bone grafting, and limited midcarpal and carpometacarpal fusion achieved good functional result without evidence of tumor recurrence or radiocarpal degeneration at 8 years postoperatively. Clinical Relevance In this case with long-term follow-up, surgical treatment of capitate GCT with limited midcarpal and carpometacarpal fusion led to a satisfactory outcome despite the alteration of wrist kinematics.

Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy

2015 ◽  
Vol 44 (7) ◽  
pp. 1027-1031 ◽  
Author(s):  
George R. Matcuk ◽  
Dakshesh B. Patel ◽  
Aaron J. Schein ◽  
Eric A. White ◽  
Lawrence R. Menendez
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Cell Tumor
Sign in / Sign up

Export Citation Format

Share Document